ZNF789
gene geneOn this page
Summary
ZNF789 (zinc finger protein 789, HGNC:27801) is a protein-coding gene on chromosome 7q22.1, encoding Zinc finger protein 789 (Q5FWF6). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm.
Source: NCBI Gene 285989 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 14 total
- MANE Select transcript:
NM_213603
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27801 |
| Approved symbol | ZNF789 |
| Name | zinc finger protein 789 |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000198556 |
| Ensembl biotype | protein_coding |
| Entrez | 285989 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 11 protein_coding, 4 retained_intron, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000331410, ENST00000379724, ENST00000447047, ENST00000448667, ENST00000465438, ENST00000468705, ENST00000481108, ENST00000481472, ENST00000483089, ENST00000488485, ENST00000493485, ENST00000494186, ENST00000877987, ENST00000918757, ENST00000918758, ENST00000951819, ENST00000951820, ENST00000951821
RefSeq mRNA: 7 — MANE Select: NM_213603
NM_001013258, NM_001350999, NM_001351000, NM_001351001, NM_001351002, NM_001351004, NM_213603
CCDS: CCDS34693, CCDS34694
Canonical transcript exons
ENST00000331410 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001324331 | 99486476 | 99487605 |
| ENSE00001595287 | 99472890 | 99473056 |
| ENSE00003469445 | 99479661 | 99479787 |
| ENSE00003533423 | 99484030 | 99484143 |
| ENSE00003646167 | 99476403 | 99476480 |
Expression profiles
Bgee: expression breadth ubiquitous, 215 present calls, max score 89.50.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.2563 / max 198.2184, expressed in 1731 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 79879 | 6.0056 | 1658 |
| 79880 | 2.0051 | 971 |
| 204539 | 0.2456 | 110 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar hemisphere | UBERON:0002245 | 89.50 | gold quality |
| right uterine tube | UBERON:0001302 | 89.39 | gold quality |
| cerebellar cortex | UBERON:0002129 | 89.38 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.03 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 89.03 | gold quality |
| cerebellum | UBERON:0002037 | 88.52 | gold quality |
| pituitary gland | UBERON:0000007 | 87.96 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 87.78 | gold quality |
| sural nerve | UBERON:0015488 | 87.54 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.33 | gold quality |
| rectum | UBERON:0001052 | 87.32 | gold quality |
| transverse colon | UBERON:0001157 | 87.09 | gold quality |
| prostate gland | UBERON:0002367 | 86.87 | gold quality |
| right testis | UBERON:0004534 | 86.83 | gold quality |
| left testis | UBERON:0004533 | 86.76 | gold quality |
| small intestine | UBERON:0002108 | 86.55 | gold quality |
| metanephros cortex | UBERON:0010533 | 86.44 | gold quality |
| left ovary | UBERON:0002119 | 86.19 | gold quality |
| right ovary | UBERON:0002118 | 85.86 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.47 | gold quality |
| spleen | UBERON:0002106 | 85.47 | gold quality |
| body of uterus | UBERON:0009853 | 85.43 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 85.40 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 85.39 | gold quality |
| thyroid gland | UBERON:0002046 | 85.17 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 84.90 | gold quality |
| body of pancreas | UBERON:0001150 | 84.67 | gold quality |
| testis | UBERON:0000473 | 84.62 | gold quality |
| intestine | UBERON:0000160 | 84.17 | gold quality |
| cortical plate | UBERON:0005343 | 84.00 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.26 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting ZNF789, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-329-3P | 99.91 | 66.56 | 1234 |
| HSA-MIR-362-3P | 99.91 | 66.38 | 1267 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-148A-5P | 99.30 | 68.27 | 1141 |
| HSA-MIR-3168 | 99.08 | 67.75 | 1384 |
| HSA-MIR-4635 | 98.74 | 67.63 | 1339 |
| HSA-MIR-603 | 98.58 | 68.28 | 1603 |
| HSA-MIR-216B-3P | 98.55 | 67.19 | 1223 |
| HSA-MIR-4275 | 97.96 | 68.42 | 1549 |
| HSA-MIR-5585-5P | 97.95 | 68.80 | 1024 |
| HSA-MIR-12127 | 97.93 | 66.67 | 793 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 789 — Q5FWF6 (reviewed: Q5FWF6)
All UniProt accessions (5): Q5FWF6, C9J3R7, C9J487, C9JUE3, F8WEN0
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5FWF6-1 | 1 | yes |
| Q5FWF6-2 | 2 | |
| Q5FWF6-3 | 3 |
RefSeq proteins (7): NP_001013276, NP_001337928, NP_001337929, NP_001337930, NP_001337931, NP_001337933, NP_998768* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050826 | Krueppel_C2H2_ZnFinger | Family |
Pfam: PF00096, PF01352
UniProt features (15 total): zinc finger region 8, splice variant 3, chain 1, domain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5FWF6-F1 | 68.50 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 51 (showing top):
LIAO_METASTASIS, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MYC_UP.V1_DN, SRC_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GLI3_TARGET_GENES, SNIP1_TARGET_GENES, ZNF407_TARGET_GENES, ZNF528_TARGET_GENES, MIR4261, MIR147B_5P, MIR548AV_5P_MIR548K, MIR8054, MIR603
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
674 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF789 | ACOT6 | Q3I5F7 | 524 |
| ZNF789 | FAM222B | Q8WU58 | 453 |
| ZNF789 | ZBED8L | Q8TCP9 | 446 |
| ZNF789 | POU1F1 | P28069 | 418 |
| ZNF789 | SSC4D | Q8WTU2 | 416 |
| ZNF789 | AGO3 | Q9H9G7 | 410 |
| ZNF789 | SREBF2 | Q12772 | 406 |
| ZNF789 | CHD8 | Q9HCK8 | 400 |
| ZNF789 | TOP2B | Q02880 | 398 |
| ZNF789 | MAP2K7 | O14733 | 396 |
| ZNF789 | KMT5A | Q9NQR1 | 396 |
| ZNF789 | MGLL | Q99685 | 389 |
| ZNF789 | CAPN1 | P07384 | 388 |
| ZNF789 | COL2A1 | P02458 | 373 |
| ZNF789 | PTK2B | Q14289 | 371 |
| ZNF789 | TET1 | Q8NFU7 | 371 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF789 | HEXIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HEXIM2 | ZNF789 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): ZNF789 (Two-hybrid), ZNF789 (Affinity Capture-RNA), ZNF789 (Cross-Linking-MS (XL-MS)), ZNF789 (Affinity Capture-MS), ZNF789 (Affinity Capture-RNA)
ESM2 similar proteins: A0JPL0, A3KN36, A7MBI1, A8MT65, B2RXC5, D3ZVT0, P08042, P21506, P51508, P52738, Q02525, Q06730, Q12901, Q2KI58, Q2M218, Q2M3W8, Q2M3X9, Q2VY69, Q49AA0, Q4R6J4, Q4V8A8, Q5FWF6, Q5HY98, Q5RB33, Q5RC79, Q5REF1, Q5T5D7, Q5VIY5, Q61967, Q6P2D0, Q6ZN11, Q86XU0, Q86Y25, Q8N782, Q8N859, Q8NB42, Q8TF39, Q8TF47, Q8WXB4, Q95K49
Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 10 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1257 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:99473607:GGAAA:G | donor_gain | 1.0000 |
| 7:99476401:A:AG | acceptor_gain | 1.0000 |
| 7:99476402:G:GG | acceptor_gain | 1.0000 |
| 7:99479771:G:GT | donor_gain | 1.0000 |
| 7:99479772:A:T | donor_gain | 1.0000 |
| 7:99494629:AACC:A | acceptor_loss | 1.0000 |
| 7:99494630:ACCT:A | acceptor_loss | 1.0000 |
| 7:99494632:C:A | acceptor_loss | 1.0000 |
| 7:99494633:T:G | acceptor_loss | 1.0000 |
| 7:99498714:A:AC | donor_gain | 1.0000 |
| 7:99498715:C:CC | donor_gain | 1.0000 |
| 7:99498715:CT:C | donor_gain | 1.0000 |
| 7:99498715:CTCGG:C | donor_gain | 1.0000 |
| 7:99498838:ATCCC:A | acceptor_gain | 1.0000 |
| 7:99498839:TCCC:T | acceptor_gain | 1.0000 |
| 7:99498840:CCC:C | acceptor_gain | 1.0000 |
| 7:99498840:CCCC:C | acceptor_gain | 1.0000 |
| 7:99498841:CC:C | acceptor_gain | 1.0000 |
| 7:99498841:CCC:C | acceptor_gain | 1.0000 |
| 7:99498841:CCCT:C | acceptor_loss | 1.0000 |
| 7:99498842:CC:C | acceptor_gain | 1.0000 |
| 7:99498842:CCTGG:C | acceptor_loss | 1.0000 |
| 7:99498843:C:CC | acceptor_gain | 1.0000 |
| 7:99498843:CTGGA:C | acceptor_loss | 1.0000 |
| 7:99498844:T:C | acceptor_loss | 1.0000 |
| 7:99499634:TCAC:T | donor_loss | 1.0000 |
| 7:99499636:A:AC | donor_gain | 1.0000 |
| 7:99499637:C:CC | donor_gain | 1.0000 |
| 7:99499637:C:CG | donor_loss | 1.0000 |
| 7:99473063:G:GT | donor_gain | 0.9900 |
AlphaMissense
2860 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:99487090:T:C | F294L | 0.997 |
| 7:99487092:T:A | F294L | 0.997 |
| 7:99487092:T:G | F294L | 0.997 |
| 7:99487174:T:C | F322L | 0.997 |
| 7:99487176:T:A | F322L | 0.997 |
| 7:99487176:T:G | F322L | 0.997 |
| 7:99487342:T:C | F378L | 0.996 |
| 7:99487344:T:A | F378L | 0.996 |
| 7:99487344:T:G | F378L | 0.996 |
| 7:99487115:G:C | R302P | 0.995 |
| 7:99487258:T:C | F350L | 0.994 |
| 7:99487260:T:A | F350L | 0.994 |
| 7:99487260:T:G | F350L | 0.994 |
| 7:99479746:G:C | R37P | 0.993 |
| 7:99486922:T:C | F238L | 0.993 |
| 7:99486924:C:A | F238L | 0.993 |
| 7:99486924:C:G | F238L | 0.993 |
| 7:99487006:T:C | F266L | 0.993 |
| 7:99487008:T:A | F266L | 0.993 |
| 7:99487008:T:G | F266L | 0.993 |
| 7:99487119:T:A | H303Q | 0.993 |
| 7:99487119:T:G | H303Q | 0.993 |
| 7:99487109:T:C | L300P | 0.992 |
| 7:99487426:T:C | F406L | 0.992 |
| 7:99487428:C:A | F406L | 0.992 |
| 7:99487428:C:G | F406L | 0.992 |
| 7:99487277:T:C | L356P | 0.991 |
| 7:99487367:G:C | R386P | 0.991 |
| 7:99487371:T:A | H387Q | 0.991 |
| 7:99487371:T:G | H387Q | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000117569 (7:99474332 C>A,G,T), RS1000352984 (7:99483456 C>T), RS1000357490 (7:99484904 G>A), RS1000466105 (7:99477713 AG>A,AGG), RS1000541800 (7:99472230 T>A,G), RS1000711935 (7:99478322 G>A), RS1000764112 (7:99478561 C>T), RS1000995788 (7:99472464 G>A), RS1001067464 (7:99485052 A>G), RS1001618019 (7:99471728 T>C), RS1001670500 (7:99471963 CTTTT>C,CT,CTT,CTTT,CTTTTT,CTTTTTT), RS1001771130 (7:99479953 C>A,T), RS1002354713 (7:99486254 G>A,C), RS1002406002 (7:99482581 T>C), RS1002513013 (7:99474693 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002925_1 | Sex hormone levels | 2.000000e-14 |
| GCST002925_10 | Sex hormone levels | 5.000000e-07 |
| GCST002925_9 | Sex hormone levels | 3.000000e-13 |
| GCST004730_2 | Facial emotion recognition (sad faces) | 3.000000e-06 |
| GCST005144_1 | Tacrolimus trough concentration in kidney transplant patients | 2.000000e-17 |
| GCST006249_21 | Serum metabolite levels | 4.000000e-11 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004730 | hormone measurement |
| EFO:0007001 | dehydroepiandrosterone sulphate measurement |
| EFO:0004908 | testosterone measurement |
| EFO:0008329 | facial emotion recognition measurement |
| EFO:0008458 | tacrolimus measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects cotreatment, decreases expression | 4 |
| Cyclosporine | decreases expression | 3 |
| bisphenol A | decreases expression | 2 |
| trichostatin A | decreases expression, increases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| Sunitinib | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Atrazine | decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Quercetin | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.